Vinay Prasad oversees vaccines, gene therapies and the blood supply. His views raise alarms for pharmaceutical companies and ...

Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to ...

The United States Food and Drug Administration has chosen Dr Vinay Prasad to lead its Center for Biologics Evaluation and Research.

While Prasad’s views may not align with many of the FDA’s traditional policies, they do fit into a broader MAHA agenda of ...

President Donald Trump unwrapped a massive drug pricing policy as CMS prepares for the next round of Medicare drug price ...

Matthew Herper joins Adam and Allison to examine Prasad’s appointment and the band of outsiders now in charge of U.S. health ...

Inspired by the world's great Lego Masters, Arovella is taking a brick-by-brick approach to building its unique cancer immunotherapy program.

Vandana Singh Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation FDA names Vinay Prasad to lead CBER, raising questions over biologics ...

Dr Vinay Prasad, a professor at UCSF and vocal critic of the ... according to CNN. Prasad’s appointment comes as the FDA plans to require future vaccines to be tested through placebo-controlled trials ...

Republicans on Capitol Hill are struggling to reach consensus on cutting the Medicaid program as they search for nearly a ...